One-carbon Therapeutics Announces Strategic Collaboration with Tempus to Advance Molecular Insights and Enable Precision Oncology Development of TH9619
Solna, Sweden, March 17h, 2026. One-carbon Therapeutics, a clinical-stage oncology
Solna, Sweden, March 17h, 2026. One-carbon Therapeutics, a clinical-stage oncology
Solna, Sweden, December 1, 2025. One-carbon Therapeutics AB, a clinical-stage
Stockholm, Sweden. November 17th, 2025. One-carbon Therapeutics AB, a clinical-stage biotechnology
One-carbon therapeutics AB is discussing the ODIN trial with several
Read the article here.
In preparation and expansion for the upcoming clinical trial, we
Professor Johann de Bono, Head of the Division of Clinical
We look forward to meeting you there!
Read a short story of One-carbon Therapeutics achievements so far